News

BMJ1d
Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
Background Studies examining the relationship between serological status (rheumatoid factor and/or anticitrullinated antibody) and rituximab treatment outcome in rheumatoid arthritis (RA) have been ...
BMJ2d
Imaging research results from the Osteoarthritis Initiative (OAI): a review and lessons learned 10 years after start of enrolment
The Osteoarthritis Initiative (OAI) is a multicentre, prospective, observational, cohort study of knee osteoarthritis (OA) that began recruitment in 2004. The OAI provides public access to clinical ...
BMJ2d
Predictive factors of work disability in rheumatoid arthritis: a systematic literature review
1 Coronel Institute for Occupational and Environmental Health, Academic Medical Centre, Research Institute Amsterdam Centre for Health and Health Care Research (AmCOGG), Amsterdam, The Netherlands 2 ...
BMJ2d
Long-term measurement of anti-adalimumab using pH-shift-anti-idiotype antigen binding test shows predictive value and transient antibody formation
1 Department of Immunopathology, Sanquin Research and Landsteiner Laboratory Academic Medical Centre, Amsterdam, The Netherlands 2 Department of Rheumatology, Jan van Breemen Research Institute/Reade, ...
BMJ2d
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
Objectives To compare over 2 years the safety, efficacy and radiographic outcomes of subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in patients with rheumatoid ...
BMJ2d
Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 5-year results of the GO-RAISE study
Objective Assess golimumab efficacy/safety through 5 years in patients with active ankylosing spondylitis (AS). Methods 356 patients with AS were randomly assigned to placebo, golimumab 50 mg or 100 ...
BMJ2d
Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group
20 Amsterdam Rheumatology & Immunology Center, Academic Medical Center, Amsterdam, The Netherlands Correspondence to Dr Robert G W Lambert, Department of Radiology and Diagnostic Imaging, University ...
BMJ2d
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients
Objectives: To identify the main causes of morbidity and mortality in patients with antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and immunological parameters with ...
BMJ2d
Erosive hand osteoarthritis: its prevalence and clinical impact in the general population and symptomatic hand osteoarthritis
1 Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands 2 Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands 3 Department of ...
BMJ3d
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study
3 Rheumatology Division, Geffen School of Medicine at the University of California–Los Angeles (UCLA), Los Angeles, CA, USA 4 Center for Innovative Therapy, University of California–San Diego, ...
BMJ4d
Skewed X chromosomal inactivation impacts T regulatory cell function in systemic sclerosis
3 Department of Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands 4 Department of Human Genetics, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands ...
BMJ5d
EULAR recommendations for patient education for people with inflammatory arthritis
19 Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, The Netherlands Correspondence to Dr Heidi A Zangi, National Advisory Unit on Rehabilitation in ...